Publications Office of the EU
Purchase and successive delivery of medicinal products used as part of chemotherapy. - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Purchase and successive delivery of medicinal products used as part of chemotherapy. Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    24/12/2024
  • Deadline
    27/01/2025
  • Opening of tenders
    27/01/2025
  • Today
    20/03/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL823 Rzeszowski
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
31
Procedure details
Tender reference number
Postępowanie nr 95, ZP.261.36-A.2024
Description

1. The subject-matter of the contract is the purchase and successive delivery of chemotherapy medicinal products listed in 31 lots for the Fryderyk Chopin University Clinical Hospital in Rzeszów. 2. Detailed description of the subject of the contract, the Contracting Authority is specified in the Price and Tender Forms – Attachments No. 1 for individual parts, which are an integral part of the SWZ. 3.The Ordering Party requires to offer items of the order which: - meet the requirements described in the Price and Offer Forms, - meet the requirements described in the CVT, - are covered by the Act of 12 May 2011 on the refund of medicines, foodstuffs intended for particular nutritional uses and medical devices – concerns medicinal products covered by the refund. 4. The scope of the contract includes the delivery of the items of the contract in the quantities specified in the Price and Offer Forms for the period of: - Part No 1 to No 22 – from 28 May 2025 for 12 months. - Part No 23 to No 28 – from 19.06.2025 for 12 months. - Lot No 29 – 31 – for 12 months from the date of conclusion of the contract. 5. The Ordering Party in Part No. 1 to No. 31 allows for the possibility of changing the term of the contract concluded with the Contractor in the event of failure to perform the entire subject of the contract during its term. In this case, the amendment of the contract requires the signing of an annex, except that the Contracting Authority shall unilaterally notify the Contractor of the proposed extension of the contract before the expiry of the period for which it was concluded. 6. The contracting authority shall not allow equivalent tenders to be submitted. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://portal.smartpzp.pl/usk
Tenders may be submitted
Electronic submission: required
https://portal.smartpzp.pl/usk
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
27/01/2025 08:00
Place of performance
PL823 Rzeszowski
PL Polska
CPV code

33652100 - Antineoplastic agents

33600000 - Pharmaceutical products

Lots (31)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.